AG002PWQ

249296-44-4 | (1R,12S)-5,8,14-triazatetracyclo[10.3.1.0^{2,11}.0^{4,9}]hexadeca-2(11),3,5,7,9-pentaene

Chemical structure of (1R,12S)-5,8,14-triazatetracyclo[10.3.1.0^{2,11}.0^{4,9}]hexadeca-2(11),3,5,7,9-pentaene, CAS 249296-44-4
AG002PWQ
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 249296-44-4
Catalog Number AG002PWQ(AGN-PC-00CKKO)
Chemical Name (1R,12S)-5,8,14-triazatetracyclo[10.3.1.0^{2,11}.0^{4,9}]hexadeca-2(11),3,5,7,9-pentaene
IUPAC Name 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2,4,6,8,10-pentaene
InChI InChI=1S/C13H13N3/c1-2-16-13-5-11-9-3-8(6-14-7-9)10(11)4-12(13)15-1/h1-2,4-5,8-9,14H,3,6-7H2
InChI Key JQSHBVHOMNKWFT-UHFFFAOYSA-N
MDL Number MFCD10001497
Molecular Formula C13H13N3
Molecular Weight 211.2624
SMILES N1=CC=NC2=CC3=C(C4CNCC3C4)C=C21
Synonyms
6,7,8,9-tetrahydro-6,10-methano-6H-pyrazino(2,3-h)benzazepine, Champix, Chantix, varenicline, varenicline tartrate, Varenicline, 249296-44-4, JQSHBVHOMNKWFT-UHFFFAOYSA-N, CP-526555, 6,10-Methano-6H-pyrazino[2,3-h][3]benzazepine, 7,8,9,10-tetrahydro-, J-501695, 6,10-Methano-6H-pyrazino[2,3-h][3]benzazepine,7,8,9,10-tetrahydro-, CHEMBL556954, NCGC00247735-01, NCGC00247735-02, 7,8,9,10-tetrahydro-6h-6,10-methanoazepino[4,5-g]quinoxaline, Varenicline (INN), AC1Q4W6H, CHEMBL1396, SCHEMBL225687, AC1L55H0, CP 526555; Champix; Chantix, BCP01413, BDBM50166908, AKOS005145561, AN-2817, CS-0396, MCULE-3341459784, RP17997, SB17430, NCGC00247735-03, CP526555, HY-10019, LS-187375, D08669, AB01568242_01, I14-1963, Varenicline|249296-44-4|Champix|Chantix|CP526555|CP-526555, 7,8,9,10-tetrahydro- 6,10-methano- 6H-pyrazino (2,3-h)(3) benzazepine, 7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino-[2,3-h][3]benzazepine, 5,8,14-Triazatetracyclo[10.3.1.02, 11.04,9]hexadeca-2(11),3,5,7,9-pentaene, 5,8,14-Triazatetracyclo[10.3.1.02,11,04,9]hexadeca-2(11),3,5,7,9-pentaene, 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene, 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9pentaene, 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2(11),3,5,7,9-pentaene, 6,10-Methano-7,8,9,10-tetrahydro-1,4,8-triaza-6H-cyclohepta[b]naphthalene, 7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino[2,3-h][3]benzazepine(Varenicline), 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2(11),3,5,7,9-pentaene; dihydrochloride, Chantix, Champix, Vareniclene, Not Available, Varenicline [INN:BAN], UNII-W6HS99O8ZO, HSDB 7591, AR-1H2911, CID170361, C13-H13-N3, CP 526555, 2209B, 7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino[2,3-h][3]benzazepine, (6R,10S)-7,8,9,10-tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline, 7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino(2,3-h)(3)benzazepine, 5,8,14-triaza-tetracyclo[10.3.1.02,11.04,9]hexadeca-2(11)-3,5,7,9-pentaene, 43215-14-1,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited